TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $761,000 | -12.8% | 55,840 | +4.7% | 0.01% | -20.0% |
| Q3 2021 | $873,000 | -0.8% | 53,311 | +2.0% | 0.01% | -9.1% |
| Q2 2021 | $880,000 | -4.6% | 52,262 | +4.0% | 0.01% | -8.3% |
| Q1 2021 | $922,000 | -4.7% | 50,233 | -5.5% | 0.01% | -7.7% |
| Q4 2020 | $967,000 | -9.3% | 53,156 | -9.0% | 0.01% | -23.5% |
| Q3 2020 | $1,066,000 | -5.2% | 58,403 | -5.9% | 0.02% | -5.6% |
| Q2 2020 | $1,124,000 | +8.0% | 62,082 | -6.7% | 0.02% | -5.3% |
| Q1 2020 | $1,041,000 | -46.8% | 66,575 | -32.9% | 0.02% | -38.7% |
| Q4 2019 | $1,958,000 | +8.8% | 99,290 | -5.0% | 0.03% | +3.3% |
| Q3 2019 | $1,800,000 | -8.3% | 104,498 | -5.8% | 0.03% | -6.2% |
| Q2 2019 | $1,963,000 | -19.1% | 110,908 | -6.9% | 0.03% | -23.8% |
| Q1 2019 | $2,426,000 | – | 119,093 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |